Mode
Text Size
Log in / Sign up

Clinical Trial Search

Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.

Phase
Intervention
Population
Results posted
Clear filters

12,372 trials

Phase 3 N=671 Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis (SAR) to Mountain Cedar in Subjects 12 Years and Older

Seasonal Allergic Rhinitis
Primary: Change From Baseline in Daily Subject-reported AM and PM Reflective TNSS Averaged Over the Two-week Treatment Period. — -1.74; -1.75; -0.72 Units on a scale — p=<0.0001
Sumitomo Pharma America, Inc. Results Jun 2012 0.0% serious AE View details

Phase 3 N=1,110 A 6 Month Safety and Efficacy Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) in the Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older

Allergic Rhinitis · Perennial Allergic Rhinitis
Primary: Change From Baseline in Daily Subject-reported AM and PM Reflective TNSS (rTNSS) Averaged Over the First 6 Weeks of Double-blind Treatment — -1.97; -1.82; -1.28 units on…
Sumitomo Pharma America, Inc. Results Jun 2012 1.8% serious AE View details

Phase 3 N=505 SPIRIT PRIME Clinical Trial

Myocardial Ischemia · Coronary Artery Stenosis · Coronary Disease
Primary: Target Lesion Failure (TLF) — 4.5; 7.7 percentage of participants
Abbott Medical Devices Results Jun 2012 48.3% serious AE View details